Region
Glenwood sells Korean films business to French strategic
Glenwood Private Equity has sold its majority stake in Korea-based industrial films producer PI Advanced Materials to France-headquartered Arkema for an enterprise value of EUR 728m (USD 817m) – six months after BPEA EQT pulled out of a deal to buy the...
Tembusu launches Singapore multi-family office
Tembusu Partners, a Singapore-based boutique private equity investment firm, has launched a multi-family office in conjunction with Reuss Private, a Swiss wealth management business.
New Zealand supply chain traceability player gets $57m
New Zealand’s Oritain, a supply chain traceability and authentication company with a presence in the US, Europe, and Australia, has raised USD 57m led by UK-based VC firm Highland Europe.
China Merchants Capital moves for Bain target Chindata
China Merchants Capital is challenging Bain Capital for Chindata Group, a largely China-focused data centre operator, having submitted a USD 3.4bn all-cash offer for the US-listed company.
Australia cybersecurity training platform getes $50m Series C
Paladin Capital Group, a US-based specialist investor in cyber solutions and infrastructure, has led a USD 50m Series C for Australia-founded Secure Code Warrior, a security training platform aimed at coders.
Legend Capital leads Series A for China CDMO CoJourney
China and US-based contract development and manufacturing organisation (CDMO) CoJourney has raised a Series A of USD 30m led by Legend Capital.
Antler expands into Malaysia through Khazanah partnership
Singapore-based accelerator and VC investor Antler is opening an office in Kuala Lumpur as it becomes the latest GP to join Khazanah Nasional’s Future Malaysia Programme.
Quadria to invest $155m in India eye hospital
Quadria Capital has invested USD 155m in Maxivision Eye Hospital, a chain of 42 eye hospitals and vision clinics across five states in southern and western India.
China's Keep raises $40m in Hong Kong IPO
Keep, a China-focused fitness app operator backed by the likes of GGV Capital, SoftBank Vision Fund 2, and 5Y Capital, traded up slightly on debut after raising HKD 313.5m (USD 40m) in a smaller-than-anticipated Hong Kong IPO.
Valuation adjustments hit Temasek's returns
Singapore’s Temasek Holdings flagged the abrupt reversal of a two-year ramp-up in valuation gains on its global direct investments across technology, healthcare, and payments on posting its worst annual return since 2016.
Australia's Next Capital closes Fund V on $251m
Australia’s Next Capital has closed its fifth lower middle market buyout fund with AUD 375m (USD 251m) in commitments, beating a target of AUD 350m.
Quadria to exit Vietnam's FV Hospital via $381m trade sale
Quadria Capital is set to exit Vietnam’s FV Hospital after a strategic buyer agreed to a USD 381.4m acquisition touted as the largest ever healthcare transaction in Vietnam.
China regulators look to streamline private equity oversight
Chinese Premier Li Qiang has signed off on new regulations aimed at facilitating private equity investment and guiding it into policy-aligned areas like semiconductors and biotech.
Partners Group recruits Australia private equity head
Partners Group has appointed Toby Mannock, previously an investment banker at ANZ, as a managing director and head of private equity in Australia.
Frontier market fundraising: Roads less travelled
As fundraising slows globally, GPs in frontier markets are more dependent than ever on multilateral development banks. That’s not a major problem now, but in a long downturn, it could become one
Deal focus: National team drives Hithium towards China IPO
Government and state-owned investors accounted for most, but not all, of Xiamen Hithium Energy Storage Technology’s USD 622m Series C, underlining where China’s strategic priorities lie
Deal focus: Aerofugia wins support for eVTOL tilt
China’s Tsinghua Holdings Capital (TH Capital) regards eVTOL as the best way to leverage electrification of the skies. Aerofugia became a preferred target by virtue of its Geely ties and commitment to tilt-rotor technology
Deal focus: COPE moves fast with Malaysia petfood play
Recognising a local champion in a pandemic-proof category, COPE Private Equity flipped a significant minority stake in Malaysian petfood maker Pet World in just over two years
Portfolio: True North and Integrace
True North has spent five years transforming Integrace from a low-margin drug portfolio into a broader, better-performing platform with digital capabilities. The M&A story isn’t finished yet
Hong Kong's VMS pursues institutional upgrade
VMS Group will reach out to fund-of-funds with China or regional mandates for its new flagship private equity fund, which is intended to mark the firm's transition from a platform that primarily serves Hong Kong family offices to one that is more institutional...
SDIC leads $97m Series A for China's Pyrotech Therapeutics
China-based Pyrotech Therapeutics, which develops treatments for inflammation and tumours, has raised a Series A of CNY 700m (USD 97m) led by state-owned investor SDIC Venture Capital.
Healthcare specialist CBC adds managing director
Asia healthcare investor CBC Group has appointed Billy Cho, formerly CFO of listed Chinese drug developer Zai Lab, as a senior managing director for private equity.
Tower Capital buys payments unit from Singapore's DBS
Tower Capital Asia has completed the fourth investment from its debut Southeast Asia fund – taking deployment past 60% - with the acquisition of a majority stake in payment solutions provider AXS from DBS Bank.